向核RNA用于体内纠正肌性缩症
Thurman M Wheeler1, Andrew J Leger, Sanjay K Pandey
1Department of Neurology, University of Rochester, 601 Elmwood Avenue, Rochester, New York 14642, USA.
Nature
|August 4, 2012
概括
反感性寡核酸 (ASO) 能够有效地向1型肌性缩症 (DM1) 中的有毒RNA. 系统性ASO治疗小鼠迅速减少疾病标志物,并显示持续的效果,提供了一个新的治疗策略.
科学领域:
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
- 在RNA治疗方面,RNA疗法.
背景情况:
- 肌性缩症1型 (DM1) 是一种遗传性疾病,由具有扩展CUG重复的有毒RNA引起.
- 在DM1中,核保留突变RNA会引起功能增益效应,使其成为治疗点.
- 反感性寡核酸 (ASOs) 的全身传递受到组织吸收不足的限制.
研究的目的:
- 为了研究系统性ASO给药对DM1基因淘汰的疗效.
- 为了确定核保留的副本是否对反意义沉默敏感.
- 探索ASOs作为调节核保留转录的一般策略.
主要方法:
- 使用了DM1.1的转基因小鼠模型.
- 系统地使用反感性寡核酸 (ASOs).
- 评估了扩展CUG (CUG(exp)) RNA和骨肌肉中的马拉特1长非编码RNA (lncRNA) 的淘汰.
- 评估了疾病的生理学,本病学和转录学特征.
主要成果:
- 系统性ASOs在DM1小鼠的骨肌中快速降低了CUG (exp) RNA.
- ASO治疗纠正了疾病特征,持续影响长达一年.
- 在肌肉中有效地击败了马拉特1 lncRNA.
- 核保留的副本表现出对反意义沉默的异常敏感.
结论:
- 系统性ASO是一种可行的策略,用于向核保留的有毒RNA,包括DM1.
- 这种方法为RNA功能增益疾病提供了持续的治疗效果.
- 这些发现为调节扩展重复和长时间核居住的lncRNA提供了可通用的方法.
相关概念视频
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
02:59Animal Mitochondrial Genetics
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
01:39Mitochondrial Protein Sorting
Mitochondria are double-membrane organelles of the eukaryotes involved in cellular metabolism, signaling, ATP synthesis, and programmed cell death. Each of these processes requires specific proteins and enzymes that must be correctly sorted to the right mitochondrial subcompartment for the proper functioning of the organelle.
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
01:21Satellite Stem Cells and Muscular Dystrophy
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...